David W. Hein serves as Vice Provost for Academic Strategy, Peter K. Knoefel Endowed Chair of Pharmacology, Professor and Chairman of the Department of Pharmacology & Toxicology, and Distinguished University Scholar at the University of Louisville. He also directs the National Institutes of Health-funded training program in Environmental Health Sciences and the National Cancer Institute-funded Cancer Education Program. Dr. Hein previously served as the founding director of the Minority Biomedical Research Support Program at Morehouse School of Medicine and chaired Departments of Pharmacology & Toxicology at Morehouse School of Medicine and the University of North Dakota School of Medicine and Health Sciences prior to his appointment at the University of Louisville in 1997. Numerous students have completed thesis and dissertation research training in his laboratory and he contributes towards instruction of undergraduate, graduate and health professional students. Dr. Hein and his wife Karla have three sons. Two sons (and their wives) completed their degree programs at the University of Louisville and the youngest son is currently enrolled.
Hein was appointed as Chester Fritz Distinguished Professor at the University of North Dakota, has received outstanding teaching awards awarded by the medical school class at both Morehouse School of Medicine and the University of North Dakota, the President's Faculty Achievement Award at Morehouse School of Medicine, the Thomas J. Clifford Faculty Achievement Award for Excellence in Research and the Burlington Northern Faculty Achievement Award for Excellence in Teaching, Research, and Creative Activity both from the University of North Dakota, an Outstanding Alumnus Award from the University of Michigan, the President's Award from the University of Wisconsin-Eau Claire, and President's Outstanding Scholarship, Research and Creative Activity Awards in Basic/Applied Sciences (2003) and Career Achievement (2014) from the University of Louisville. He presented the Astor Visiting Lectureship at the University of Oxford (UK) and serves as a Visiting Professor at the Université Paris Diderot (France) and Wenzhou Medical University (P.R. China). He has been elected to membership in the Academy of Pharmacology Educators of the American Society for Pharmacology and Experimental Therapeutics.
Hein has led development and implementation of pharmacology and toxicology PhD partnerships with Wenzhou Medical University, Cairo University, and Jilin University.
Hein's research program includes pharmacogenomics, genetic predisposition to environmental disease, molecular epidemiology, cancer prevention and education. The work has been funded continuously since 1983 by grants totaling over $31M from the National Institutes of Health and other federal and private foundations. He has coauthored over 225 peer-reviewed journal articles and book chapters, 75 gene sequences, and over 550 abstracts with over 9000 citations (h-index=47) in the scientific literature.